Moleculin Biotech, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Moleculin Biotech, Inc. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $0.00.
- Moleculin Biotech, Inc. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $0.00.
- Moleculin Biotech, Inc. stock issued during period, value, issued for services for the quarter ending 2024-03-31 was $37.00K.
- Moleculin Biotech, Inc. stock issued during period, value, issued for services for the quarter ending 2018-12-31 was $0.00.
- Moleculin Biotech, Inc. stock issued during period, value, issued for services for fiscal 2025 was $965.00K, a 2508.11% increase from fiscal 2024.
- Moleculin Biotech, Inc. stock issued during period, value, issued for services for fiscal 2024 was $37.00K.
- Moleculin Biotech, Inc. stock issued during period, value, issued for services for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Moleculin Biotech, Inc. stock issued during period, value, issued for services for fiscal 2017 was $89.00K, a 43.67% decline from fiscal 2016.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $965.00K 10-K · filed 2026-03-18 | |
| 2024-12-31 | $37.00K 10-K · filed 2026-03-18 | |
| 2024-03-31 | $37.00K 10-Q · filed 2025-11-13 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 10-K · filed 2019-02-21 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $0.00 derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-14 | $0.00 derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $89.00K 10-K · filed 2019-02-21 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $247.00K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $247.00K derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | $89.00K 10-Q · filed 2018-05-14 | $247.00K derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $158.00K 10-K · filed 2018-03-28 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |